Risk factors for depression and anxiety in pregnant women during the COVID-19 pandemic: Evidence from meta-analysis
- PMID: 35245344
- PMCID: PMC8896698
- DOI: 10.1371/journal.pone.0265021
Risk factors for depression and anxiety in pregnant women during the COVID-19 pandemic: Evidence from meta-analysis
Abstract
Background: The prevalence of anxiety and depression in pregnant women has significantly increased after the spread of COVID-19 throughout the world. We carried out this meta-analysis to reveal the information about risk factors for depression and anxiety in pregnant women during the COVID-19 pandemic.
Methods: We searched the PubMed, Embase and CNKI (China National Knowledge Infrastructure) databases for all articles. The odds ratio (OR) corresponding to the 95% confidence interval (95% CI) was used to assess the risk factors for mental health. The statistical heterogeneity among studies was assessed with the Q-test and I2 statistics.
Results: We collected 17 studies including 15,050 pregnant women during the COVID-19 pandemic. Our results found that factors including decrease in the perception of general support and difficulties in household finances have damage effects on anxiety, and factors including undereducated, unemployed during pregnancy, with a chronic physical illness before pregnancy, decrease in the perception of general support, difficulties in household finances, disobey the isolation rules, and smoking during pregnancy have increased risk of depression.
Conclusion: Our meta-analysis revealed some risk factors for mental health in pregnant women during COVID-19 pandemic. Mental health interventions in pregnant women may involve targeted methods individually.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Rasmussen SA, Kelley CF, Horton JP, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: What Obstetricians Need to Know. Obstetrics and gynecology. 2021;137(3):408–14. Epub 2020/12/29. doi: 10.1097/AOG.0000000000004290 Registry Advisory Committee and the Solriamfetol Pregnancy Registry Advisory Committee. In addition, she serves as a litigation consultant on behalf of Hoffmann-La Roche for a product liability claim regarding an alleged birth defect. These are not relevant to this article or COVID-19. Colleen F. Kelley is supported by research grants to her institution from Gilead Sciences, ViiV, Moderna, and Novavax. The other authors did not report any potential conflicts of interest. - DOI - PMC - PubMed
-
- Schwartz DA. An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Archives of pathology & laboratory medicine. 2020;144(7):799–805. Epub 2020/03/18. doi: 10.5858/arpa.2020-0901-SA . - DOI - PubMed
-
- Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al.. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet (London, England). 2020;395(10226):809–15. Epub 2020/03/11. doi: 10.1016/S0140-6736(20)30360-3 . - DOI - PMC - PubMed
